Dion's Monday ETFs Winners and Losers
The risky futures-back natural gas funds were rising sharply today.
02/21/12 - 02:33 PM EST
TheStreet Ratings Top 10 Rating Changes
TheStreet Ratings released rating changes on 106 U.S. common stocks for week ending February 17, 2012. 83 stocks were upgraded and 23 stocks were downgraded by our stock model.
02/21/12 - 01:55 PM EST
Threshold Drug Delays Pancreatic Cancer
Threshold reports positive results from a mid-stage study of its pancreatic cancer drug TH-302.
02/21/12 - 01:51 PM EST
A Negative Vote for Vivus Obesity Drug, Says 'FDA Panel Whisperer'
An analysis of experts' past voting records shows Vivus faces a stiff test Wednesday from an FDA panel reviewing the obesity drug Qnexa.
02/21/12 - 10:39 AM EST
Corcept Has Upside Following Drug Approval
- Tickers in this article:
- CORT
FDA approved Corcept's Korlym for Cushing's syndrome.
02/21/12 - 12:54 PM EST
The Case for Shorting Elan Into Upcoming Alzheimer's Trial Results
The amyloid beta hypothesis doesn't explain Alzheimer's, which leaves Elan and its partners in trouble.
02/21/12 - 07:00 AM EST
Dion's Friday ETF Winners and Losers
The natural gas ETFs are up today following a favorable inventory report.
02/17/12 - 02:50 PM EST
Gilead Suffers First Hep C Drug Setback
Gilead's GS-7977 fails to cure hard-to-treat hepatitis C patients, showing the wonder drug has flaws.
02/17/12 - 10:46 AM EST
Biotech Stock Mailbag: Vivus, Chelsea, BioCryst
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.
02/17/12 - 05:30 AM EST
- Tickers in this article:
- IDIX
CEO Ronald Renaud Jr. discusses getting one of his company's drugs into a combination study and the possibility of being acquired.
02/16/12 - 03:06 PM EST
These Drugs Stocks Will Win FDA Approval
Contestants in TheStreet's FDA Drug-Approval Contest forecast their winners and losers.
02/16/12 - 12:04 PM EST
BioSante: A Penny Stock Still Overvalued
Day traders are propping up BioSante's valuation. At some point, the numbers start to matter.
02/16/12 - 07:15 AM EST


Connect with TheStreet